Concepedia

Craig Wilson

CW

Statistics

Publications

20

Citations

4.3K

H-Index

16

Active since

1987

Affiliations

Takeda (United States)(Current)

University of Connecticut

Harvard University

Cleveland Clinic

University of Chicago

Craig Wilson is an author at Takeda (United States) specializing in medicine, cardiovascular disease, and diabetes.

Top concepts

Publications per year

1987–2024

20

Publications

20

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

William B. White, Christopher P. Cannon, Simon Heller et al. · New England Journal of Medicine · 2013 · 2.5K citations · Full text

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

Faı̈ez Zannad, Christopher P. Cannon, William C. Cushman et al. · The Lancet · 2015 · 748 citations

, , +11

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control

Ralph A. DeFronzo, P. Fleck, Craig Wilson et al. · Diabetes Care · 2008 · 224 citations · Full text

EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE)

William B. White, George L. Bakris, Richard M. Bergenstal et al. · American Heart Journal · 2011 · 148 citations

, , +10

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Richard E. Pratley, Jane E.B. Reusch, P. Fleck et al. · Current Medical Research and Opinion · 2009 · 131 citations

1–5 of 20